DOI: https://doi.org/10.22141/2224-0721.0.2.42.2012.176852

A1chieve® Study: Global problems of Compensation of Diabetes Mellitus Type 2

V.I. Pankiv, Марина Владимировна Власенко, N. A. Kravchun, Евгений Николаевич Марциник

Abstract


No abstract


References


Приказ МЗ Украины № 574 от 05.08.2009.

Heller S., Colagiuri S., Vaaler S., Wolffenbuttel B.H.R. et al. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes // Diabetic Medicine. — 2004. — Vol. 21. — P. 769-775.

De Leeuw I., Selam J.-L., Skeie S. et al. Insulin detemir-based used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin // Diabetes Obes. Metab. — 2005. — Vol. 7, № 1. — P. 73-82.

Garber A.J., Clauson P., Pedersen C.B., Kølendorf K. Lower risk of hypoglycemia with insulin detemir than with NPH insulin in older persons with type 2 diabetes: a pooled analysis of phase 3 trials // J. Am. Geriatric. Soc. — 2007. — 55(11). — 1735-40.

Meneghini L.F., Rosenberg K.H., Koenen C., Merilainen M.J., Luddeke H.J. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVETM // Diabetes Obes. Metab. — 2007. — 9(3). — 418-27.

Luddeke et al. PREDICTIVE™ — a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort // Diabetes, Obesity and Metabolism. — 2007. — 9. — 428-434.

Dornhorst A., Hernandez F.O., Koenen C., Lüddeke H.-J. Levemir (insulin Detemir) Reduces Weight and Improves Blood Glucose Levels Poster presentation at: 19th world congress of the International Diabetes Federation. — Capetown, South Africa, December 3–7, 2006.

Selam J.L., Koenen C., Weng W., Meneghini L. Improving glycemic control with insulin detemir using the 303 algorithm in insulin naive patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study // Curr. Med. Res. Opin. — 2008. — 24(1). — 11-20.

Porte D.Jr., Baskin D.G., Schwartz V.W. Insulin signaling in the central nervous system a critical role in metabolic homeostasis and disease from C. elegans to human // Diabetes. — 2005. — 54(5). — 1264-76.

Hennige A.M., Sartorius T. et al. Tissue selectivity of insulin detemir action in vivo // Diabetologia. — 2006. — 49. — 1274-1282.

Schwartz M.W. Brain parthways controlling food intake and body weight // Science. — 2000. — 289. — 2066-7.

Horden S.V.M., Wrigt J.E. et al. Comparison of effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-hr euglycaemic clamp // Diabetologia. — 2005. — 48. — 420-426.

Hermanse K., Tamer S. The advantage of less weight gain with baseline obesity when insulin Detemir rather than NPH insulin added to oral agents in Type 2 Diabetes // Diabetes. — 2005. — 54 (Suppl.1). — A 64.

Haak T. et al. Lower within subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes // Diabetes Obesity Metabolism. — 2005. — 7(1). — 56-64.

Постанова Кабінету міністрів України від 19 серпня 2009 р. № 877 «Про затвердження Державної цільової програми «Цукровий діабет»» на 2009–2013 роки.

Global guideline for Type 2 diabetes. — Brussels: International Diabetes Federation, 2005.

Nathan D.M. et al. Medical management of hyperglycaemia in type 2 Diabetes Mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes // Diabetologia. — 2009. — 52. — 17-30.

Va/DoD Clinical practice Guideline for the management of diabetes mellitus, August 2010, Version 4.0.

Road Maps To Achieve Glycemic Control in Type 2 Diabetes Mellitus // Endocrine Practice. — 2007. — Vol. 13, № 3 May/June.

Asakura T., Seino H. Dosing accuracy of two insulin pre-filled pens // Current Med. Research and Opinion. — 2008. — 24. — 1429-1434.

Valensi et al. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix® 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study // Int. J. Clin. Pract. — 2009. — 63, 3. — 522-531.






Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта